A carregar...
Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events
AIMS: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein that enhances degradation of the LDL receptor. While agents that inhibit PCSK9 markedly reduce atherogenic lipoproteins and show great promise for event reduction, it is unknown whether plasma PCSK9 levels predict inci...
Na minha lista:
| Publicado no: | Eur Heart J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744620/ https://ncbi.nlm.nih.gov/pubmed/26508163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv568 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|